SMTL ID : 5hlw.1

Crystal structure of c-Met mutant Y1230H in complex with compound 14

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.97 Å

Oligo State

monomer

Ligands

1 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 7 residues within 4Å: Chain A: T.121, V.122, K.123, F.288, G.290, E.291, H.292 Ligand excluded by PLIP

1 x 62E: 1-[2-(1-ethylpiperidin-4-yl)ethyl]-3-(6-{[6-(thiophen-2-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)urea(Non-covalent)

62E.2: 16 residues within 4Å: Chain A: I.28, A.52, L.84, L.101, P.102, Y.103, M.104, K.105, H.106, G.107, N.153, M.155, A.165, D.166, A.170, H.174 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:A.52, A:L.84, A:L.101, A:H.174 Hydrogen bonds: A:Y.103, A:M.104, A:M.104, A:M.104, A:D.166 Water bridges: A:F.167, A:F.167 pi-Stacking: A:H.174, A:H.174

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ugolini, A. et al., Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). J.Med.Chem. (2016)

Release Date

2016-11-23

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor